Fumi Nakamura, Sachiko Seo, Honoka Arai, Yuka Nakamura, Tomoyuki Handa, Wataru Takahashi, Shiho Furuichi, Fusako Nagasawa, Jiro Tadokoro, Shigeharu Tsurumi, Yuko Nakamura, Ko Sasaki, Motoshi Ichikawa, Kinuko Mitani (Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan)
Session information
Oral Session
Oral Session 2-11A AML: Clinical Study (1)
Sat. Oct 12, 2019 9:00 AM - 10:00 AM No.11 (Tokyo International Forum, 5F G502)
Chair: Takahiro Yamauchi (Department of Hematology and Oncology, Univesity of Fukui)
Cancelled
Tze Shin Leong1, Siong Leng Hon1, Siew Lian Chong1, Fidhora Syazarin1, Sen Mui Tan1, Tee Chuan Ong1, Jerome Tan1, Ngee Siang Lau1, Shahnaz Alkudsi1, Veena Selvaratnam1, Jameela Sathar1, Kian Boon Law2 (1.Department of Haematology, AmpangHospital, Ampang, Selangor, Malaysia, 2.Clinical Trial Unit, National Clinical Research Centre, Ampang Hospital, Ampang, Selangor, Malaysia)
Hisayuki Yokoyama1, Takahiko Yasuda2, Yuichi Ishikawa3, Kensuke Usuki4, Shingo Yano5, Yoshikazu Ito6, Shiro Koh7,8, Toru Kiguchi9, Yasuhiko Miyata10, Hitoshi Kiyoi3, Itaru Matsumura11, Yasushi Miyazaki12, Hiroyoshi Hattori2, Dai Nishijima2, Matsuo Yamamoto2, Akiko Saito2, Hiroki Kurahashi13, Yuichi Shiraishi14, Satoru Miyano15, Masashi Sanada2, Seishi Ogawa16, Keizo Horibe2,17 (1.Department of Hematology, Sendai Medical Center, NHO, Sendai, Japan, 2.Clinical Research Center, Nagoya Medical Center, NHO, Nagoya, Japan, 3.Department of Hematology and Oncology, Nagoya University, Nagoya, Japan, 4.Department of Hematology, NTT Medical Center, Tokyo, Japan, 5.The Jikei University School of Medicine, Tokyo, Japan, 6.Department of Hematology, Tokyo Medical University, Tokyo, Japan, 7.Department of Hematology, Fuchu Hospital, Izumi, Japan, 8.Department of Hematology, Osaka City University, Osaka, Japan, 9.Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan, 10.Department of Hematology, Nagoya Medical Center, NHO, Nagoya, Japan, 11.Department of Hematology, Kindai University Faculty of Medicine, Osaka, Japan, 12.Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan, 13.Division of Molecular Genetics, Fujita Health University, Toyoake, Japan, 14.National Cancer Center, Tokyo, Japan, 15.Human Genome Center, University of Tokyo, Tokyo, Japan, 16.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 17.Department of Pediatrics, Nagoya Medical Center, NHO, Nagoya, Japan)
Toshiki Saito, Koji Hamano, Matsuo Yamamoto, Takahiko Yasuda, Shuhei Kondo, Masashi Sanada, Hirokazu Nagai, Keizo Horibe (NHO Nagoya Medical Center, Nagoya, Japan)
Daisuke Hidaka1, Masahiro Onozawa1, Shinichi Fujisawa2, Satoshi Yamamoto3, Yutaka Tsutsumi4, Yoshihito Haseyama5, Takahiro Nagashima6, Akio Mori7, Shuichi Ota8, Hajime Sakai9, Toshimichi Ishihara10, Takuto Miyagishima11, Yasutaka Kakinoki12, Mitsutoshi Kurosawa13, Hajime Kobayashi14, Hiroshi Iwasaki15, Takeshi Kondo7, Takanori Teshima1,2 (1.Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan, 2.Division of Laboratory and Transfusion, Hokkaido University Hospital, Sapporo, Japan, 3.Sapporo City General Hospital, Sapporo, Japan, 4.Hakodate Municipal Hospital, Hakodate, Japan, 5.Tonan Hospital, Sapporo, Japan, 6.Japanese Red Cross Kitami Hospital, Kitami, Japan, 7.Aiiku Hospital, Sapporo, Japan, 8.Sapporo Hokuyu Hospital, Sapporo, Japan, 9.Teine Keijinkai Hospital, Sapporo, Japan, 10.Kin-ikyo Chuo Hospital, Sapporo, Japan, 11.Kushiro Rosai Hospital, Kushiro, Japan, 12.Asahikawa City Hospital, Asahikawa, Japan, 13.Hokkaido Cancer Center, Sapporo, Japan, 14.Obihiro Kosei General Hospital, Obihiro, Japan, 15.Sapporo Kosei General Hospital, Sapporo, Japan)
Kensuke Matsuda1, Taisuke Jo2, Kazuhiro Toyama1, Kumi Nakazaki1, Hideo Yasunaga3, Mineo Kurokawa1,4 (1.Hematol., Tokyo Univ., Tokyo, Japan, 2.Health Services Research, Tokyo Univ., Tokyo, Japan, 3.Clinical Epidemiology and Health Economics, Tokyo Univ., Tokyo, Japan, 4.Cell Therapy and Transplantation Medicine, Tokyo Univ., Tokyo, Japan)